← Back to Search

Other

Traditional Moxibustion for Peripheral Neuropathy (DSP/DM Trial)

N/A
Waitlist Available
Led By J. Anastasi, PhD
Research Sponsored by New York University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up change from baseline neurological physical assessment after 3 wks of twice-wkly treatment sessions
Awards & highlights

DSP/DM Trial Summary

This study is evaluating whether a non-pharmacologic approach to pain management can improve quality of life for people with diabetes.

Eligible Conditions
  • Peripheral Neuropathy
  • Neuropathic Pain
  • Diabetes

DSP/DM Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~change from baseline neurological physical assessment after 3 wks of twice-wkly treatment sessions
This trial's timeline: 3 weeks for screening, Varies for treatment, and change from baseline neurological physical assessment after 3 wks of twice-wkly treatment sessions for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Gracely Pain Scale
Secondary outcome measures
Subjective Peripheral Neuropathy Screen (SPNS)
Other outcome measures
Clinical Global Severity & Improvement Scale
Neurological Sensory Testing (NST)

DSP/DM Trial Design

4Treatment groups
Active Control
Placebo Group
Group I: Traditional MoxibustionActive Control1 Intervention
Participants receive Active Traditional Moxibustion - a protocol aimed at reducing neuropathic pain/discomfort.
Group II: Smokeless MoxibustionActive Control1 Intervention
Participants receive Active Smokeless Moxibustion - a protocol aimed at reducing neuropathic pain/discomfort.
Group III: Waitlist ControlActive Control1 Intervention
WaitList (Control) No treatment. Subjects receive all aspects of study participation with the exception of exposure to Moxibustion. Note. All participants randomized to the Control will be offered active protocol moxibustion treatments, at no cost, at the end of their study participation.
Group IV: Placebo Moxibustion ControlPlacebo Group1 Intervention
Participants receive Placebo Moxibustion - a protocol that mimics the active protocol but is not. Note. All participants randomized to the Control will be offered active protocol moxibustion treatments, at no cost, at the end of their study participation.

Find a Location

Who is running the clinical trial?

New York UniversityLead Sponsor
226 Previous Clinical Trials
314,211 Total Patients Enrolled
1 Trials studying Peripheral Neuropathy
122 Patients Enrolled for Peripheral Neuropathy
J. Anastasi, PhDPrincipal InvestigatorNew York University

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Recent research and studies
clinicaltrials.govStudy
Distal Peripheral Neuropathy in Type 2 Diabetes
Joyce K. Anastasi 2019. "Distal Peripheral Neuropathy in Type 2 Diabetes". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT05104047.
~8 spots leftby Apr 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top